Long Term Effects of Proximal Small Bowel Exclusion by Duodenal-Jejunal Bypass Liner on Weight Reduction and Glycemic Control in Diabetic Patients

Obesity and type 2 diabetes mellitus (T2DM) have become a substantial burden on public health in the last century and advocate different strategies to mitigate them [1]. Proximal small bowel diversion bears prominent beneficial metabolic effects associated with augmentation of the incretin system and accelerated glucose handling in the distal part of the gut [2, 3]. Roux-en-Y gastric bypass (RYGB) surgery exhibits these advantages [4 –6] and is an effective tool for weight reduction and glycemic control [7].

Source: Surgery for Obesity and Related Diseases - July 28, 2018 Category: Surgery Authors: Liat Deutsch, Limor Ben-Haim, Yael Sofer, Nathan Gluck, Erwin Santo, Sigal Fishman Tags: Original articles Source Type: research